MedPath

Comparison between effect of two drugs- amlodipine and telmisartan on people with high blood pressure on their blood sugar levels,lipid rofile and renal profile.

Phase 4
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2024/07/071545
Lead Sponsor
Midnapore medical college and hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient aged between 18 and 65 years.

2.Patients newly diagnosed with hypertension(systolic blood pressure =140 mm hg and/or diastolic pressure =90 mmhg)

3.Patients with no history of diabetes mellitus,renal disease or hyperlipidemia.

4.Patients who provide informed consent to participate in the study.

Exclusion Criteria

1.Patients who are already taking antihypertensive medications.

2.Patients with a history of allergic reactions to amlodipine or telmisartan.

3.Patients with a history of chronic diseases,such as diabetes mellitus,renal disease,or hyperlipidemia.

5.Pregnant or lactating women.

6.Patients who are unable or unwilling to provide informed consent.

7.Patients who are not taking any other medications that interfere glycemic status,lipid profile and renal parameters.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The study will give us knowledge and effectiveness and adverse effects of amlodipine and telmisartan and comparing the effects of these two drugs on glycemic status ,lipid profile and renal parameters. <br/ ><br>Timepoint: Data will be collected at baseline,3 months and 6 months. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To study the adverse effect of both the drugs in these patients. <br/ ><br>Timepoint: Data will be collected at baseline, third & sixth month. <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath